CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies

Objectives. To assess CCL18 and OX40L as biomarkers of interstitial lung disease (ILD) and/or progressive fibrosing (PF-) ILD in idiopathic inflammatory myopathies (IIMs). Methods. Patients with IIMs seen in our center from July 2020 to March 2021 were consecutively enrolled. ILD was detected by hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanatta, Elisabetta, Martini, Andrea, Depascale, Roberto, Gamba, Anna, Tonello, Marta, Gatto, Mariele, Giraudo, Chiara, Balestro, Elisabetta, Doria, Andrea, Iaccarino, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217155/
https://www.ncbi.nlm.nih.gov/pubmed/37238199
http://dx.doi.org/10.3390/diagnostics13101715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217155/
https://www.ncbi.nlm.nih.gov/pubmed/37238199
http://dx.doi.org/10.3390/diagnostics13101715

Ejemplares similares